NO992157L - Laktosefrie, ikke-hygroskopiske og vannfrie farmas°ytiske sammensetninger av deskarboetoksyloratadin - Google Patents

Laktosefrie, ikke-hygroskopiske og vannfrie farmas°ytiske sammensetninger av deskarboetoksyloratadin

Info

Publication number
NO992157L
NO992157L NO992157A NO992157A NO992157L NO 992157 L NO992157 L NO 992157L NO 992157 A NO992157 A NO 992157A NO 992157 A NO992157 A NO 992157A NO 992157 L NO992157 L NO 992157L
Authority
NO
Norway
Prior art keywords
hygroscopic
pharmaceuticals
lactose
anhydrous
free
Prior art date
Application number
NO992157A
Other languages
English (en)
Other versions
NO992157D0 (no
NO325611B1 (no
Inventor
Martin P Redmon
Hal T Butler
Stephen A Wald
Paul D Rubin
Original Assignee
Sepracor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27365195&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO992157(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sepracor Inc filed Critical Sepracor Inc
Publication of NO992157L publication Critical patent/NO992157L/no
Publication of NO992157D0 publication Critical patent/NO992157D0/no
Publication of NO325611B1 publication Critical patent/NO325611B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
    • A61K31/621—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO19992157A 1997-02-07 1999-05-04 Laktosefrie, ikke-hygroskopiske og vannfrie farmasoytiske sammensetninger av deskarboetoksyloratadin, samt anvendelse derav ved behandling av sykdommer og forstyrrelser NO325611B1 (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US3732597P 1997-02-07 1997-02-07
US4518497P 1997-04-30 1997-04-30
US5305097P 1997-07-21 1997-07-21
PCT/US1998/002328 WO1998034614A1 (en) 1997-02-07 1998-02-06 Lactose-free, non-hygroscopic and anhydrous pharmaceutical compositions of descarboethoxyloratadine

Publications (3)

Publication Number Publication Date
NO992157L true NO992157L (no) 1999-05-04
NO992157D0 NO992157D0 (no) 1999-05-04
NO325611B1 NO325611B1 (no) 2008-06-23

Family

ID=27365195

Family Applications (2)

Application Number Title Priority Date Filing Date
NO19992157A NO325611B1 (no) 1997-02-07 1999-05-04 Laktosefrie, ikke-hygroskopiske og vannfrie farmasoytiske sammensetninger av deskarboetoksyloratadin, samt anvendelse derav ved behandling av sykdommer og forstyrrelser
NO20075846A NO20075846L (no) 1997-02-07 2007-11-14 Laktosefrie, ikke-hygroskopiske og vannfrie farmasoytiske sammensetninger av deskarboetoksyloratadin, samt anvendelse derav ved behandling av sykdommer og forstyrrelser

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO20075846A NO20075846L (no) 1997-02-07 2007-11-14 Laktosefrie, ikke-hygroskopiske og vannfrie farmasoytiske sammensetninger av deskarboetoksyloratadin, samt anvendelse derav ved behandling av sykdommer og forstyrrelser

Country Status (28)

Country Link
US (2) US20020123504A1 (no)
EP (2) EP1614421A3 (no)
JP (1) JP2001511184A (no)
KR (5) KR20060132053A (no)
CN (1) CN1132579C (no)
AR (3) AR011114A1 (no)
AT (1) ATE345133T1 (no)
AU (1) AU6271998A (no)
BR (1) BR9806157A (no)
CA (1) CA2267136C (no)
CO (1) CO4940445A1 (no)
CZ (1) CZ119499A3 (no)
DE (1) DE69836424T2 (no)
DK (1) DK0969836T3 (no)
ES (1) ES2271986T3 (no)
HU (1) HUP0001527A3 (no)
MY (1) MY136999A (no)
NO (2) NO325611B1 (no)
NZ (1) NZ335041A (no)
PE (1) PE71699A1 (no)
PL (1) PL192075B1 (no)
PT (1) PT969836E (no)
RU (1) RU2209627C2 (no)
SK (1) SK286035B6 (no)
TW (1) TW522014B (no)
UA (1) UA70290C2 (no)
WO (1) WO1998034614A1 (no)
ZA (1) ZA98977B (no)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2325014C (en) * 1998-07-10 2002-05-28 Schering Corporation 8-chloro-6,11-dihydro-11-(4-piperidylidene)-5h-benzo[5,6]cyclohepta[1,2-b]pyridine oral compositions
US6100274A (en) * 1999-07-07 2000-08-08 Schering Corporation 8-chloro-6,11-dihydro-11- ](4-piperidylidine)-5H-benzo[5,6]cyclohepta[1,2-bpyridine oral compositions
CA2383214A1 (en) * 1999-09-22 2001-03-29 Schering Corporation Treating allergic and inflammatory conditions
US6114346A (en) * 1999-10-22 2000-09-05 Schering Corporation Treating sleep disorders using desloratadine
MY125516A (en) 1999-11-16 2006-08-30 Smithkline Beecham Plc Novel composition based on thiazolidinedione and metformin and use
WO2001045668A2 (en) * 1999-12-20 2001-06-28 Schering Corporation Stable extended release oral dosage composition comprising pseudoephedrine and desloratadine
AU2276801A (en) * 1999-12-20 2001-07-03 Schering Corporation Extended release oral dosage composition
KR101199654B1 (ko) * 1999-12-20 2012-11-08 머크 샤프 앤드 돔 코포레이션 안정한 서방출형의 경구 투여용 조성물
US7405223B2 (en) 2000-02-03 2008-07-29 Schering Corporation Treating allergic and inflammatory conditions
ATE352305T1 (de) * 2003-03-12 2007-02-15 Teva Pharma Stabile pharmazeutische zusammensetzungen mit desloratadine
US20060135547A1 (en) * 2003-03-12 2006-06-22 Toth Zoltan G Stable pharmaceutical compositions of desloratadine and processes for preparation of polymorphic forms of desloratadine
US7390503B1 (en) 2003-08-22 2008-06-24 Barr Laboratories, Inc. Ondansetron orally disintegrating tablets
WO2005065047A2 (en) * 2003-12-23 2005-07-21 Sun Pharmaceutical Industries Limited Stable oral composition containing desloratadine
TWI415635B (zh) 2004-05-28 2013-11-21 必治妥施貴寶公司 加衣錠片調製物及製備彼之方法
ZA200701036B (en) * 2004-07-16 2008-05-28 Cipla Ltd Anti-histaminic composition
WO2006020534A2 (en) * 2004-08-09 2006-02-23 Dr. Reddy's Laboratories Ltd. Stabilized desloratadine composition
CA2547274A1 (en) * 2005-05-20 2006-11-20 Dr. Reddy's Laboratories Limited Stable desloratadine compositions
US20070004671A1 (en) * 2005-05-20 2007-01-04 Agarwal Sudeep K Stable desloratadine compositions
US20070014855A1 (en) * 2005-07-12 2007-01-18 Rahul Gawande S Stable desloratadine compositions
US20080118555A1 (en) * 2005-10-20 2008-05-22 Glenmark Pharmaceuticals Limited Stable pharmaceutical composition containing desloratadine
CA2541045A1 (en) * 2006-03-24 2007-09-24 Pharmascience Inc. A descarbonylethoxyloratadine containing pharmaceutical composition
EP1862462A1 (en) * 2006-04-10 2007-12-05 Ranbaxy Laboratories Limited Process for the preparation of desloratadine
RU2008151047A (ru) * 2006-06-07 2010-07-20 Сандоз АГ (CH) Стабильные и биодоступные композиции и новая форма деслоратадина
ECSP077628A (es) 2007-05-03 2008-12-30 Smithkline Beechman Corp Nueva composición farmacéutica
TR200806298A2 (tr) 2008-08-22 2010-03-22 Bi̇lgi̇ç Mahmut Farmasötik formülasyon
PL2398468T3 (pl) 2009-02-17 2017-06-30 Krka, D.D., Novo Mesto Kompozycje farmaceutyczne zawierające zasadę prasugrelu lub jej farmaceutycznie dopuszczalne kwasowe sole addycyjne i sposoby ich otrzymywania
EP2269586B1 (en) 2009-07-01 2011-09-21 Alfred E. Tiefenbacher (GmbH & Co. KG) Pharmaceutical composition comprising desloratadine
ES2709487T3 (es) 2010-05-10 2019-04-16 Lesvi Laboratorios Sl Formulaciones farmacéuticas estables que contienen un antihistamínico
TR201009396A2 (tr) 2010-11-11 2012-05-21 Bi̇lgi̇ç Mahmut Desloratadin granüller
CN102813640B (zh) * 2012-09-06 2016-12-21 无锡万全医药技术有限公司 一种含地氯雷他定的软胶囊及其制备方法
US20170135969A1 (en) 2015-11-12 2017-05-18 Jds Therapeutics, Llc Topical arginine-silicate-inositol for wound healing
GB2568849B (en) * 2016-09-01 2022-08-10 Nutrition 21 Llc Magnesium biotinate compositions and methods of use
CN113230235B (zh) * 2021-04-15 2022-11-11 海南普利制药股份有限公司 含地氯雷他定的复方缓释胶囊及其制备方法
US20250170143A1 (en) * 2022-04-14 2025-05-29 Mayo Foundation For Medical Education And Research Methods of treating ocular fibrotic pathologies

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1548022A (en) * 1976-10-06 1979-07-04 Wyeth John & Brother Ltd Pharmaceutial dosage forms
HU194864B (en) * 1984-02-15 1988-03-28 Schering Corp Process for production of 8-chlor-6,11-dihydro-11-(4-piperidilidene)-5h-benzo (5,6)-cyclo-hepta (1,2-b) pyridine and its salts
US4990535A (en) * 1989-05-03 1991-02-05 Schering Corporation Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine
WO1992011034A1 (en) * 1990-12-18 1992-07-09 The Wellcome Foundation Limited Agents for potentiating the effects of antitumor agents and combating multiple drug resistance
RU2068689C1 (ru) * 1992-09-24 1996-11-10 Товарищество с ограниченной ответственностью "Лекрон" Способ получения таблеток парацетамола
US5314697A (en) * 1992-10-23 1994-05-24 Schering Corporation Stable extended release oral dosage composition comprising loratadine and pseudoephedrine
DE4442999A1 (de) * 1994-12-02 1996-06-05 Hexal Pharma Gmbh Pharmazeutische Zusammensetzung mit einem aktiven Loratidin-Metaboliten
US5595997A (en) * 1994-12-30 1997-01-21 Sepracor Inc. Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine
US5939426A (en) * 1997-02-28 1999-08-17 Sepracor Inc. Methods for treating urinary incontinence using descarboethoxyloratadine
US6162829A (en) * 1997-10-17 2000-12-19 Atlantic Pharmaceuticals, Inc. (3R,4R)-Δ8 -tetrahydrocannabinol-11-oic acids useful as antiinflammatory agents and analgesics
US5997905A (en) * 1998-09-04 1999-12-07 Mcneil-Ppc Preparation of pharmaceutically active particles

Also Published As

Publication number Publication date
AR064895A2 (es) 2009-05-06
CN1246794A (zh) 2000-03-08
EP0969836A1 (en) 2000-01-12
DK0969836T3 (da) 2007-03-19
TW522014B (en) 2003-03-01
KR100624259B1 (ko) 2006-09-13
KR20070086880A (ko) 2007-08-27
UA70290C2 (uk) 2004-10-15
PL334232A1 (en) 2000-02-14
CN1132579C (zh) 2003-12-31
PL192075B1 (pl) 2006-08-31
NO20075846L (no) 1999-05-04
AU6271998A (en) 1998-08-26
US20060079489A1 (en) 2006-04-13
AR064896A2 (es) 2009-05-06
HUP0001527A2 (hu) 2001-04-28
BR9806157A (pt) 2001-01-09
MY136999A (en) 2008-12-31
US20020123504A1 (en) 2002-09-05
WO1998034614A1 (en) 1998-08-13
SK47299A3 (en) 2000-03-13
CZ119499A3 (cs) 1999-08-11
AR011114A1 (es) 2000-08-02
NO992157D0 (no) 1999-05-04
ATE345133T1 (de) 2006-12-15
EP1614421A3 (en) 2006-02-15
EP1614421A2 (en) 2006-01-11
EP0969836B1 (en) 2006-11-15
DE69836424D1 (de) 2006-12-28
ZA98977B (en) 1998-07-30
KR20000068914A (ko) 2000-11-25
KR20080003012A (ko) 2008-01-04
ES2271986T3 (es) 2007-04-16
NZ335041A (en) 2000-09-29
CA2267136C (en) 2000-11-28
HUP0001527A3 (en) 2002-01-28
HK1024187A1 (en) 2000-10-05
PT969836E (pt) 2007-01-31
PE71699A1 (es) 1999-08-03
KR20060076330A (ko) 2006-07-04
JP2001511184A (ja) 2001-08-07
CO4940445A1 (es) 2000-07-24
KR20060132053A (ko) 2006-12-20
NO325611B1 (no) 2008-06-23
DE69836424T2 (de) 2007-09-27
SK286035B6 (sk) 2008-01-07
RU2209627C2 (ru) 2003-08-10

Similar Documents

Publication Publication Date Title
NO992157D0 (no) Laktosefrie, ikke-hygroskopiske og vannfrie farmas°ytiske sammensetninger av deskarboetoksyloratadin
NO20021449D0 (no) Substituerte 2-tio-3,5-dicyano-4-aryl-6-aminopyridiner og anvendelse derav
DE69936091D1 (de) Transaktionssystem
TR199802106A3 (tr) Sübstitüe edilmis izokinolin-3-karbon asidi amidleri.
DE69941529D1 (de) Tragbares Informationsverarbeitungssystem
NO20012158D0 (no) Substituerte 2-fenylbenzimidazoler, fremgangsmåte til fremstilling og anvendelse derav
NO991151D0 (no) Forbindelse og anvendelse derav
NO20020304D0 (no) Konserverte farmasöytiske preparater
IS2076B (is) Asýl-píperasínil-pýrimídínafleiður, framleiðsla og notkun þeirra sem lyfja
DE69842251D1 (de) Multiserver Workflow-System
IS5942A (is) 3,3-bíarýlpíperidín og 2,2-bíarýlmorfólín afleiður
DK1068238T3 (da) Integrinheterodimer og subunit deraf
NO991278L (no) FremgangsmÕte og system for sikker netthandel
NO308213B1 (no) Substituerte indanylidinacetylguanidiner, deres anvendelse og medikamenter inneholdende forbindelsene
NO20003268D0 (no) Hyperhydrert kitikolin, fremgangsmÕte og anvendelse
NO305410B1 (no) B°lgekraftverk
DK1051156T3 (da) Farmaceutiske præparater
NO976006L (no) Kombinert langsgÕende og tverrgÕende sporf°lging
SE9801216D0 (sv) Pharmaceuticals
SE9800469D0 (sv) Pharmaceuticals
DK1107793T3 (da) Dextran-leptin-konjugater, farmaceutiske præparater og relaterede fremgangsmåder
DK0969815T3 (da) Farmaceutiske præparater
SE9702958D0 (sv) Pharmaceuticals
NO981089D0 (no) Epoksy-azetidinoner, fremstilling og anvendelse derav
DK1127052T3 (da) Substituerede 2-phenylbenzimidazoler, fremstilling og anvendelse heraf

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees